SIRT1 and breast carcinoma: At the opposite, in (ER-) cell lines MDA-MB 453, MDA-MB 231 and MDA-MB 468, SIRT1 deficiency induces a 2.5 to 4-fold increase of H3k4ac and H3k9ac expression on EZH2 and EP300 promoters, indicating that SIRT1 contributes to the 2 oncogenes repression; hence exerting tumor-suppressive properties in breast cancer triple-negative subtypes.